Informações:
Falhas:
ID
29140
Descrição
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.; ODM derived from: https://clinicaltrials.gov/show/NCT00744367
Link
https://clinicaltrials.gov/show/NCT00744367
Palavras-chave
Versões (1)
- 28/02/2018 28/02/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
28 de fevereiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus, Type 2 NCT00744367
Eligibility Diabetes Mellitus, Type 2 NCT00744367
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00744367
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adult patients, 18-75 years age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Diabetes Mellitus, Non-Insulin-Dependent | Pioglitazone U/day | Metformin U/day
Item
type 2 diabetes receiving pioglitazone (>= 30 mg/day) and metformin (>= 1500 mg/day) for at least 12 weeks prior to screening;
boolean
C0011860 (UMLS CUI [1])
C0071097 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0025598 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
C0071097 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0025598 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
Glucohemoglobin measurement
Item
hba1c >=7.0% and <=10.0% at screening;
boolean
C0202054 (UMLS CUI [1])
Body mass index | Asians
Item
bmi >= 25 (>23 for asians) and <=45 kg/m2 at screening;
boolean
C1305855 (UMLS CUI [1])
C0078988 (UMLS CUI [2])
C0078988 (UMLS CUI [2])
Stable body weight Duration
Item
stable weight +/-5% for at least 12 weeks prior to screening.
boolean
C0517386 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Diabetes Mellitus, Insulin-Dependent | Complications of Diabetes Mellitus Metabolic | Ketoacidosis | Hyperosmolar Coma
Item
history of type 1 diabetes mellitus or acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma in the previous 6 months;
boolean
C0011854 (UMLS CUI [1])
C0342257 (UMLS CUI [2,1])
C0311400 (UMLS CUI [2,2])
C0220982 (UMLS CUI [3])
C0020457 (UMLS CUI [4])
C0342257 (UMLS CUI [2,1])
C0311400 (UMLS CUI [2,2])
C0220982 (UMLS CUI [3])
C0020457 (UMLS CUI [4])
Complications of Diabetes Mellitus Clinical Significance
Item
evidence of clinically significant diabetic complications;
boolean
C0342257 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
Gastrointestinal Disease Symptomatic
Item
clinically symptomatic gastrointestinal disease;
boolean
C0017178 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Cardiomyopathy Post Transplantation | Cerebrovascular accident
Item
myocardial infarction, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within the previous 6 months;
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0878544 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0040732 (UMLS CUI [3,3])
C0038454 (UMLS CUI [4])
C0010055 (UMLS CUI [2])
C0878544 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0040732 (UMLS CUI [3,3])
C0038454 (UMLS CUI [4])
Hemoglobinopathy | Chronic anemia
Item
known hemoglobinopathy or chronic anemia.
boolean
C0019045 (UMLS CUI [1])
C0581384 (UMLS CUI [2])
C0581384 (UMLS CUI [2])